Abstract
QScience.com is the innovative and collaborative, peer-reviewed, online publishing platform from Hamad bin Khalifa University Press (HBKU Press). It offers a fast and transparent Open Access scholarly publishing process, which is centered on the author, bringing their research to a global audience.
Highlights
Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary
Dear Editor, The points raised by Al-Kindi are well made and we accept concerns raised about the current lack of reliable reversal agents for the NOACs
This is relevant to surgeons and interventionists, not least when performing percutaneous ablation therapy for atrial fibrillation, which is routinely undertaken without discontinuing warfarin in those patients who are on this therapy
Summary
Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
